FIELD: pharmaceutical chemistry.
SUBSTANCE: group of inventions includes a compound with formula 1, specific compounds indicated in the claims, as well as pharmaceutical and cosmetic compositions based thereon. In Formula 1, R1, R2 and R3 are each independently hydrogen, alkyl, cycloalkyl, halogen, hydroxy, carboxyl, amino, cyano, alkyl alkoxyphosphate, -NR6 R7, -CH2 NR8 R9, -N=NR42, aryl, alkylcarbonyl, alkylarylcarbonyl, alkoxycarbonyl, haloalkyl, cycloalkoxy, heterocycloalkyl, alkylaryl, arylalkyl; R4 is alkyl, cycloalkyl, halogen, hydroxy, carboxyl, amino, alkylalkoxyphosphate, -NR6 R7, -CH2 NR8 R9, -N=NR42, aryl, alkylcarbonyl, alkylarylcarbonyl, alkoxycarbonyl, haloalkyl, cycloalkoxy, heterocycloalkyl, alkylaryl, arylalkyl; where said alkyl or alkoxy group contains 1-6 carbon atoms, cycloalkyl is C3-C10 cycloalkyl, aryl is C6-C20 aryl, and heteroaryl, heterocycloalkyl are monovalent radicals containing 6 ring atoms and 1 a heteroatom selected from oxygen or nitrogen; R5 is selected from the group consisting of formulas 2, 3 and 4 of the claims, or R5 is a polycyclic functional group selected from spiro[4.5]decanil, 4,5,6,7-tetrahydropyrazolo[1,5 -a]pyridinyl, 1,2,3,5,6,7-hexahydro-s-indacenyl or norbornanyl; X1 and X 2 are each independently nitrogen (N) or carbon (C), provided that at least one carbon atom (C) is present; is a single bond or a double bond; L represents -NH- or -CH 2 NH-.
EFFECT: derivatives of pyrazolo[3,4-b]pyridine, pyrazolo[3,4-d]pyrimidine and pyrazolo[3,4-b]pyrazine, which have the properties of a proliferation promoter of dermal ridge cells and are used to prevent or treat hair loss.
11 cl, 1 dwg, 1 tbl, 123 ex
formula 1
Title | Year | Author | Number |
---|---|---|---|
BENZOTHIAZOLE COMPOUNDS AND METHODS FOR THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS | 2018 |
|
RU2778370C2 |
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
COMPOUNDS HAVING INHIBITORY ACTIVITY RELATIVELY TO PDE9A AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2788147C2 |
GLUCOKINASE ACTIVATORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AS ACTIVE INGREDIENT | 2008 |
|
RU2450001C2 |
DIAZACARBAZOLES AND METHODS OF APPLICATION | 2009 |
|
RU2515972C2 |
PRODRUGS OF CONJUGATED BICYCLIC C5aR ANTAGONISTS | 2019 |
|
RU2794327C2 |
PYRROLO[2,3-C]PYRIDINES AS IMAGING AGENTS FOR NEUROFIBRILLAR TANGLES | 2015 |
|
RU2695373C2 |
PYRROLO[2,3-C]PYRIDINES AS IMAGING AGENTS FOR NEUROFIBRILLARY TANGLES | 2015 |
|
RU2788916C2 |
HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2016 |
|
RU2710743C2 |
KINASE INHIBITORS APPLICABLE FOR TREATING MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES | 2007 |
|
RU2482112C2 |
Authors
Dates
2023-03-17—Published
2019-05-02—Filed